A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy

The peroxisome proliferator-activated receptor-α (PPAR-α) agonist fenofibrate ameliorates cardiac hypertrophy; however, its mechanism of action has not been completely determined. Our previous study indicated that a disintegrin and metalloproteinase-17 (ADAM17) is required for angiotensin II-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Si-Yu, Lu, Hui-Qin, Yan, Qiu-Jiang, Zou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076894/
https://www.ncbi.nlm.nih.gov/pubmed/30105051
http://dx.doi.org/10.1155/2018/7916953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076894/
https://www.ncbi.nlm.nih.gov/pubmed/30105051
http://dx.doi.org/10.1155/2018/7916953

Ejemplares similares